Article
Biglycan Overexpression Predicts Poor Prognosis of Gastric Cancer
2021-05-04
Abstract excerpt
<h4>Background: </h4> Biglycan (BGN) encodes an extracellular matrix (ECM) proteoglycan. However, the potential diagnostic and prognostic value of BGN in gastric cancer (GC) have not yet been reported. In this analysis, BGN expression in GC was evaluated across the Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA), and Oncomine databases, and verified using immunohistochemistry (IHC). The relationship...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a9e60c7b-06da-5a18-b649-633502dd76e3
- DOI
- 10.21203/rs.3.rs-419860/v1
